Contrasting TNF Pharmaceuticals (TNFA) and Its Competitors
Insider & Institutional Ownership 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 44.7% of shares of all “Diagnostic substances” companies are held by institutional investors. 1.2% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 12.5% of shares of all “Diagnostic substances” companies are held by insiders. Strong institutional ownership is an […]
Insider & Institutional Ownership 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 44.7% of shares of all “Diagnostic substances” companies are held by institutional investors. 1.2% of TNF Pharmaceuticals shares are held by insiders. Comparatively, 12.5% of shares of all “Diagnostic substances” companies are held by insiders. Strong institutional ownership is an […]
